Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Persivia™ Secures $15 Million Growth Financing from Petrichor Healthcare Capital Management


Company to aggressively focus on sales, marketing and expand product capabilities.

Persivia Inc. (“Persivia” or the “Company”), the AI-driven value-based care solution provider, has announced today that it has closed a $15 million financing from Petrichor Healthcare Capital Management (“Petrichor”), completing its Series C round to support an array of growth initiatives.

The financing highlights an impressive growth trajectory for the Company. Persivia has grown from 65 customers at the end of 2015 to over 330 hospitals and provider groups on its platform today, a CAGR of over 70%. In the past six months, Persivia has added over 50 hospitals participating in the value-based Bundled Payments program and has also partnered with a large hospital group for Chronic Care Management deployment.

“We have a leading product for the healthcare ecosystem which is uniquely positioned to facilitate all stakeholders in the sector. Over the last four years, we have largely operated in stealth mode, relying on word-of-mouth referrals from loyal customers, with a keen focus on the development of our platform. This capital raise will be used to further build our sales and marketing efforts and drive awareness of our solutions to the wider healthcare industry. Our platform is very unique in using AI to support all data sources in all venues of care and for all value-based care models. If you are a system with 23 different EHRs, multiple Hospitals, 12 different claims feed and participate in Medicare Advantage, an ACO, Bundled Payments, CPC+ and/or take Commercial and Medicaid risk, there is no better platform for you in the industry today. We typically replace 5-6 different isolated point solutions when deploying to such a customer,” said Dr. Mansoor Khan, Founder and CEO of Persivia. “With this financing, we will now focus on driving large scale sales and marketing efforts to such customers,” announced Mansoor.

“We are pleased to partner with Persivia as they advance into their next stage of growth. The Persivia team has established an impressive customer base and revenue profile solely on the back of its superior product capabilities. We look forward to helping the Company drive growth as they broaden their sales and marketing to a larger group of customers. Persivia is a prime example of a founder-led, innovation-driven business with a next-generation solution tailored to a healthcare landscape that has too long been plagued by underdeveloped IT offerings,” said Tadd Wessel, Founder and Managing Partner of Petrichor, who will also take a seat on Persivia’s Board.

About Persivia Inc.:

Persivia Inc. offers healthcare providers the industry’s most comprehensive platform for managing multiple concurrent Value Based Care programs and data from dozens of sources. Built on the Soliton® AI engine, Persivia’s CareSpace® platform provides care coordination and analytics capabilities incorporating the industry’s most comprehensive AI-based clinical knowledge database. Persivia is committed to easing the growing burden of Value Based Care on healthcare providers and to transforming the healthcare ecosystem in the US.

For more information please visit http://www.persivia.com, email us at info@persivia.com or call us at +1(978) 856-4600

About Petrichor Healthcare Capital Management:

Petrichor Healthcare Capital Management partners with world-class healthcare managers and businesses to provide customized investment structures and support. The Petrichor team of investment professionals comes from highly-regarded financial institutions including OrbiMed Advisors and Fortress Investment Group. Collectively, the team has completed over 75 investments representing more than $5 billion in invested capital and has held over 25 board seats. Petrichor maintains a deep in-house understanding of healthcare products and services, including scientific, technical, and commercial expertise. This healthcare expertise, together with a breadth of experience investing across sectors, geographies, and capital structures, provides a strong competitive advantage.

For more information on Petrichor, please see http://www.petrichorcap.com or contact the firm at info@petrichorcap.com.

Share article on social media or email:

First Long Island CBD Boutique Launches Online Wellness Store


Long Island CBD Store

STOA Wellness launches online CBD store

Our site is all about empowering customers with the information they need and easy access to a carefully selected array of CBD products that meet our stringent standards.

On Sep. 8, 2019, General Cannabis Corp (OTCQX: CANN) — the regulated cannabis industry’s national resource — held the grand opening for Long Island’s first-of-a-kind boutique CBD storefront. Located at 7A Northern Boulevard in Greenvale, New York, STOA Wellness offers a thoughtfully curated lineup of CBD wellness products tailored to health-conscious consumers.

The retail shop is staffed by a team of athletes who know firsthand how CBD products can complement a holistic wellness regimen, from anti-anxiety treatments to pain relief solutions. According to Michael Feinsod, CEO of General Cannabis, education is a critical part of his company’s mission: “For first-time customers, CBD can be intimidating. Our highly trained staff of athletes and health specialists is here to help customers learn more about what CBD is, how it can help alleviate their symptoms and how to pick the right products for their unique needs.”

For those outside the Greenvale area, STOA Wellness offers the same array of fitness-focused CBD products via an easy-to-shop online store. Andrew Motola, Managing Director of Retail, explains that the website embraces the same philosophy that guides their Greenvale operations: “Our site is all about empowering customers with the information they need and easy access to a carefully selected array of CBD products that meet our stringent standards. Whether they’re walking through our doors in Greenvale or logging on from the comfort of their homes, we’re committed to providing an educational and enjoyable shopping experience for every customer.”

To learn more about CBD wellness products from General Cannabis, visit http://www.stoawellness.com or visit the Greenvale location at 7A Northern Boulevard in Greenvale, New York.

About STOA Wellness

STOA Wellness is more than a place to find CBD. It’s a place to come face-to-face with subject matter experts. A place to find real recovery solutions. And a place for the fitness-inspired to learn how to incorporate CBD into their wellness regimen. STOA Wellness offers an expertly curated collection of results-oriented CBD products with the educational materials and staff know-how to back it up.

STOA Wellness

7A Northern Blvd

Greenvale, NY 11549

516.801.0095

http://www.stoawellness.com

Share article on social media or email:

HealthcareSource Releases 2019 Recruitment Benchmarks, Highlights Featured in 2019 Report: State of Healthcare Recruiting


With the Affordable Care Act bringing more than 20 million people into the healthcare system, aging baby boomers, historically low unemployment, and hundreds of thousands of healthcare workers retiring each year, recruiting qualified talent … has become an ongoing epic challenge.

HealthcareSource®, the leading provider of talent management solutions for the healthcare industry, today released the “2019 Report: State of Healthcare Recruiting,” based on Recruitment Benchmarks by Lean Human Capital. With the hundreds of thousands of data points collected, the 10th annual benchmark features senior living/post-acute data for the first time.

The Lean Human Capital Healthcare Recruitment Benchmarks have become an annual barometer of healthcare recruitment practices and employment trends. The goal of the study is to gauge the health of the healthcare recruiting industry, provide a macro view of labor supply and demand across the industry, identify key drivers, and outline essential strategies to optimize every process in sourcing, recruiting, and hiring. The 2019 report identifies the five most significant recruiting challenges in healthcare, the top trends in key acute and post-acute job families, and the nine best practices for healthcare recruitment in 2019.

“One word sums up the state of the healthcare job market in 2019 – stressed,” said Michael Grossi, HealthcareSource Chief Executive Officer. “With the Affordable Care Act bringing more than 20 million people into the healthcare system, aging baby boomers, historically low unemployment, and hundreds of thousands of healthcare workers retiring each year, recruiting qualified talent for both replacement hires and new jobs has become an ongoing epic challenge.”

Lean Human Capital surveyed more than 3,500 hospitals including post-acute facilities, employing nearly 900,000 clinicians and other staff on six key dimensions of recruiting: speed, efficiency, quality-of-hire, productivity, cost, and quality of service. Data was collected on requisitions for positions in 18 clinical and operational job families, from direct-care nurses to food service workers.

According to the Bureau of Labor Statistics, hospitals alone employed 5.238 million workers in July 2019, and the unemployment rate in the sector was an astonishingly low 1 percent. As of June 2019, there were 1.164 million job openings in healthcare and social services, and healthcare added an average of about 33,000 new jobs per month in each of the 12 months ending July 2019. Those statistics, combined with the technical complexity of medicine, make healthcare one of the most challenging industries to recruit for.

“Healthcare recruiting is not getting any easier, and the challenges healthcare organizations are facing today are likely to only become more complex,” said Carla Kennedy, Managing Director of Lean Human Capital. “The success of any healthcare recruiting organization depends largely on its resources and investment in talent acquisition to meet the organization’s needs and the strength of efforts to evaluate and optimize processes across sourcing, recruiting, and hiring. In this hypercompetitive market, talent acquisition teams need to take action now by finding efficiencies, implementing effective strategies, and ensuring they have the right data to make the important business decisions for today and tomorrow.”

The 2019 Recruitment Benchmark study also shows the business impact of working with Lean Human Capital’s advisory services team. Organizations in their second year or beyond of a successful recruitment transformation journey with Lean Human Capital benefit from:


  • 89-percent rate of positions filled to offers extended
  • 13 days faster time-to-fill for critical, hard-to-fill roles
  • 24 percent fewer openings per recruiter

Obtain a copy of “2019 Report: State of Healthcare Recruiting” here.

About HealthcareSource

HealthcareSource® is the only comprehensive talent management suite designed specifically to support the healthcare talent ecosystem. Our software, services, content, and analytics enable more than 3,500 healthcare organizations, senior care providers, and staffing agencies, spanning over 6,000 locations, to ensure quality patient and client care by recruiting, retaining, and developing quality talent. HealthcareSource and its award-winning healthcare talent management solutions have been recognized by industry analysts and trade groups.

Share article on social media or email:

Nihon Medi-Physics Accelerates “Theranostics” Development


News Image

The new research facility has been completed for novel radiopharmaceuticals.

In radiopharmaceutical research with alpha-emitters, NMP’s new site is the first in Japan with the capacity of investigational new drug manufacturing.

Nihon Medi-Physics (NMP), the leading radiopharmaceutical company in Japan, announced the completion of its new research facility on September 10, 2019. NMP invested JPY3.3Billion for the construction.

NMP is accelerating strategic plans and processes to establish Theranostics*1, the fusion of therapeutics and diagnostics. NMP utilizes multiple techniques to arrive at a comprehensive image/therapy regime for cancer patients using a common molecule, such as an antibody or a peptide, to function as a Drug Delivery System (DDS) *2. In this concept, therapeutic and diagnostic agents can be concurrently developed by changing the radioisotopes labeled with the common molecule; for instance alpha emitters*3 such as Actinium-225 (225Ac) for therapeutic agent and gamma emitters such as Zirconium-89 (89Zr) for diagnostic one

The new site will play an indispensable role in the development of new drugs within the Theranostics concept based on exploratory research, through to investigational new drug manufacturing under a GMP compliant environment. In radiopharmaceutical research with alpha-emitters such as 225Ac, NMP’s new site is the first in Japan with this capacity.

NMP has been advancing this research theme which was funded by the second Cyclic Innovation for Clinical Empowerment (CICLE*4) initiative organized and managed by the Japan Agency for Medical Research and Development (AMED). To accelerate Theranostics, NMP is actively pursuing invitation-based collaborations and alliances with academic and private organizations in and outside Japan. At the same time, NMP utilizes its distinguished skills to handle radionuclides cultivated through NMP’s long-standing experience in the radiopharmaceutical business.    

Sources

*1: Theranostics: A term to denote the fusion of therapeutics and diagnostics.

*2: Drug Delivery System: Engineering technologies and systems that deliver a drug in minimum quantity to the targeted organ or tissue, etc., with the right timing, by controlling the pharmacokinetics of the drug so that the maximum outcome can be obtained.

*3: Alpha emitters: In comparison to other types of radiation, alpha emitters are effective in destroying targeted cancer cells. At the same time, their short path length in human tissue minimizes irradiation of surrounding healthy tissues. Therefore, alpha emitters like 225Ac are attracting a lot of attention globally as radionuclides in applications for cancer treatment.

*4: CiCLE: One of the grant programs promoted by the Japan Agency for Medical Research (AMED) for the establishment of infrastructure to respond to medical needs, the creation of an environment for open innovation, and venture development based on industry-academia government collaboration. See AMED website for more information: https://www.amed.go.jp/en/program/list/07/01/001.html

Nihon Medi-Physics Co., Ltd.

Nihon Medi-Physics Co., Ltd. (NMP) is a leading company for radiopharmaceuticals in Japan, engaged in R&D, manufacturing, and distribution. NMP’s stable and reliable supply of quality products has contributed to society over the years. With continuous challenges to new business opportunities in the “Development of Theranostics”, “Application of digital technology in healthcare” and “Expansion of radiopharmaceutical business in Asia”, NMP anticipates to further contribute to the health and well-being of societies into the future.

Contacts

Tokyo

General Affairs Group

Corporate Communication

Nihon Medi-Physics Co., Ltd.

3-4-10, Shinsuna, Koto-ku, Tokyo

136-0075

Office: +81.3.5634.7006

E-mail: nmp_press@nmp.co.jp

Website: https://www.nmp.co.jp/eng

New York City

Tsutomu Abe, Ph.D.

Manager, Technical Representative

Sumitomo Chemical America Inc.

150 East 42nd Street, Suite 701

New York, NY 10017

Office: +1.212.572.8211

E-mail: tabe@sumichem.com

Share article on social media or email:

Seeking Crunch for Keto and High Protein Diets? New Cereal/Snack Pieces Introduced for Manufacturers


https://www.prweb.com/

70% Protein Whey-Os(tm) and 50% Protein Whey-Vs(tm)

70% Protein Whey-Os™ deliver high Protein content with minimal carbohydrate, making them an excellent option for consumers following Keto Diets. Whey-Os™ can be offered as a cereal or snack provide the desirable crunchy texture of high-carbohydrate products like cereals, chips or crackers – products that consumers miss on Keto Diets.

50% Protein Whey-Vs™ provide High-Protein Diets with a new choice for breakfast or break time. Although Whey-Vs™ contain 50% protein, they still retain the light texture and crispy bite of much lower protein counterparts. High-protein foods have been shown to improve appetite control, satiety and muscle mass development which are helpful in weight management.

Either new product can be flavored by ZRB with sweet or savory seasonings for cereal, snack or trail mix-add-in applications. Cinnamon Vanilla, Honey Nut, Barbeque or Cheese seasonings can applied topically or Vanilla flavoring can be incorporated into the base pieces.

Ingredients for ZRB 70% Protein Whey-Os™ are Whey Protein Isolate, Whey Protein Concentrate, Tapioca Starch and Calcium Carbonate. ZRB 50% Protein Whey-Vs™ Ingredients are Whey Protein Concentrate, Brown Rice Flour and Calcium Carbonate. The new products are Soy-Free, Gluten-Free, Kosher and Halal.

New products 70% Protein Whey-Os™ and 50% Protein Whey-Vs™ join Zumbro River Brand’s line of High Protein Better-for-you cereal and snack offerings and Z-Crisps® High Protein Crisps for nutrition bars. Zumbro River Brand also specializes in contract manufacturing, offering Batch Fluid Bed Agglomeration and High Protein Extrusion services. For further information visit our website – http://www.zumbroriverbrand.com.

Share article on social media or email:

Bahamas Hospitals Authority Enhances Systems and Processes with Help from SANTA ROSA CONSULTING


Santa Rosa Consulting Logo

“All levels of our public health system share the common vision of delivering the highest quality in healthcare, and this requires us working shoulder to shoulder with an outstanding partner like Santa Rosa” – Catherine Weech, PHA Managing Director

Santa Rosa Consulting, Inc., a leading provider of management consulting and information technology (IT) services for the healthcare industry, has completed the first phase of a comprehensive strategic and technological initiative to advance the Public Hospitals Authority (PHA) of the Commonwealth of The Bahamas towards a fully integrated health information management system (iHIMS).

The first phase included: launching the implementation of Infor’s CloudSuite Financials ERP; strengthening PHA’s IT capabilities and infrastructure; standardization of ‘best practice’ processes and roles; as well as planning and preparations to evaluate and select an electronic health record solution. Specific focus is also being given to improving PHA’s revenue cycle results and advancing with these other activities.

Speaking to the significant impact the implementation of the iHIMS, PHA Managing Director Catherine Weech described it as key among the Authority’s commitment to transform healthcare throughout the Bahamas. “All levels of our public health system share the common vision of delivering the highest quality in healthcare, and this requires us working shoulder to shoulder with an outstanding partner like Santa Rosa,” she added. Weech continued, “Physicians and clinicians must have access to a national patient health record with vital health information from across any and all care delivery locations. Doing so requires new approaches and technologies tailored as much as possible to the unique environment and culture of The Bahamas.”

Bill Leander, Executive Vice President and Chief Strategy Officer for Santa Rosa described the partnership with PHA as a wonderful opportunity to implement a plan that will link the Islands of The Bahamas in the name of healthcare and IT innovation, “We are truly grateful and honored to work with PHA from strategy to execution to transform healthcare for all Bahamians.” Leander continued, “Great patient care, and a great health system, are the sum of so many things that must be executed nearly flawlessly every single time. In the same way, this bold national initiative also has many moving parts that all must come together to achieve our shared goals.”

ABOUT SANTA ROSA CONSULTING:

Santa Rosa Consulting provides management advisory services and technical consulting expertise across the full range of IT vendor products and systems, and empowers better healthcare by designing, creating, staffing and sustaining IT solutions that help make healing happen. Founded in 2008, Santa Rosa Consulting is managed by industry veterans with an average of 20 years of healthcare information technology experience. Santa Rosa is recognized for delivering world-class services and solutions and has received Modern Healthcare’s Best Places to Work in Healthcare award multiple years in a row. For more information, visit https://www.santarosaconsulting.com/ or call (866) 944-4772.

ABOUT PUBLIC HOSPITALS AUTHORITY:

The Public Hospitals Authority is a public corporation responsible for the management of our nation’s three (3) public hospitals, the Princess Margaret Hospital, Grand Bahama Health Services (inclusive of the Rand Memorial Hospital and the ten public clinics in Grand Bahama), and the Sandilands Rehabilitation Centre as well as their associated agencies the National Emergency Medical Services (NEMS) and the Supplies Management Agency (SMA). The PHA is a dynamic organization where more than 4,000 employees pool their talent, expertise and determination to deliver the highest level of care possible to the people of the Commonwealth of The Bahamas. For more information, please visit the PHA website at phabahamas.org or visit our Facebook page at https://www.facebook.com/PHACommunications/ or call (242)502.1400.

Share article on social media or email:

Jax Beach Grand Opening Set for Saturday, Oct. 12 as AltMed Florida Opens Second Medical Cannabis Dispensary on the First Coast


https://www.prweb.com/

AltMed Florida Dispensary Design

With our patient count growing so rapidly in Jacksonville, we accelerated the opening of our Jacksonville Beach location to best serve the First Coast.

AltMed Florida, one of the fastest growing Medical Marijuana Treatment Centers (MMTC) in the state (source: OMMU), has announced the grand opening of its second MÜV™ Medical Cannabis Dispensary on the First Coast – scheduled at 10 a.m. Saturday, Oct. 12 at 1198 Beach Blvd., Suite 4 in Jacksonville Beach.

Located at Beach Plaza Shopping Center at the corner of Beach Boulevard and 12 Street South, this ninth MÜV Dispensary opened in Florida will offer an extensive selection of award-winning products including flower, pre-rolls, a wide range of vaporizer pens, metered dose inhalers, topicals, oral sprays, patent-pending encapsulation formulations in its Tinctures, 72-Hour Transdermal patches and transdermal gels. MÜV is also recognized for having one of the widest selections of concentrates for patients needing macro-dosing options.

“Since our June 8th opening of MÜV Jacksonville on Hendricks Avenue, MÜV has rapidly become recognized by medical cannabis patients both for its award-winning product portfolio and highly trained staff,” said MUV Marketing Director Todd Beckwith. “With our patient count growing so rapidly in Jacksonville, we accelerated the opening of our Jacksonville Beach location to best serve the First Coast.”

During the grand opening, licensed Florida medical cannabis patients will receive 25 percent off their entire first purchase and the first 100 patients will receive a MÜV SWAG bag with their purchase. Patients can also order online at http://www.muvfl.com for express pickup or delivery.

Like AltMed Florida’s eight other locations (Apollo Beach, Clearwater, Gainesville, Jacksonville/San Marco, Longwood/Orlando, Sarasota, Tampa and Wellington/West Palm), the new Jacksonville Beach MÜV Dispensary stands out from others because it’s designed as a premium experience. Think Apple store, with a modern, open-concept design and expert staff with extensive training.

“Our dispensaries set the standard for quality products, service and overall patient experience at our current locations and we’re excited to offer our premium MÜV medical cannabis brand to more people in Northeast Florida,” said AltMed Florida CEO John Tipton. “Our dispensaries are unlike anything in the state and we invite licensed patients throughout Clay, Duval, Nassau and St. Johns counties and beyond to visit our newest state-of-the-art location.”

The MÜV brand already has a wide following in other legal medical cannabis markets, including Arizona, where it has won five Best of Arizona medical cannabis awards. MÜV products are sold exclusively in Florida at MÜV dispensaries because, unlike other states, Florida does not allow wholesale of product between license holders – only products that license holders make themselves can be sold in their dispensaries.

For more information about the new ADA-compliant Jacksonville Beach MÜV Medical Cannabis Dispensary, including hours and available MÜV products, visit http://www.MÜVFL.com.

AltMed Florida is on pace to open 40 MÜV Medical Cannabis Dispensaries across the state, all supplied by its 200,000-square-foot, state-of-the-art cultivation facility. Visit this link for images of AltMed Florida’s cultivation operations and watch this brief video to see what makes AltMed Florida and its MÜV™ Medical Cannabis Dispensaries stand out.

About Plants of Ruskin, LLC – d.b.a. AltMed Florida, LLC – With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.

About AltMed Enterprises – Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated medical cannabis company that brings compassion, community engagement and pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.

About MÜV™ – The MÜV brand of cannabis infused products was launched in Arizona in 2016 and quickly gained international attention and recognition. In its first six months alone, MÜV received four best of Arizona medical cannabis awards, including two first prizes for its proprietary Ethanol extractions that are the basis of all MÜV products.

Forward-Looking Statements – To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.

Media contact: Colin Trethewey – Colin@PRmediaNow.com / 813.480.1354

Tackling Rampant Waste in Healthcare


https://www.prweb.com/

Hundreds of billions of dollars spent on healthcare in the U.S. are wasted annually

By embracing more retail-like operating practices, health systems and hospitals can reduce costs, improve employee morale, ease administrative burdens and deliver better patient experiences – Kevin Fleming, CEO, Loyale Healthcare

In startling new research published just this week by the Journal of the American Medical Association (JAMA), researchers from Humana, Inc. and the University of Pittsburgh School of Medicine estimated that the cost of waste in the U.S. Healthcare system amounts to between $760 billion and $935 billion in healthcare spending annually. That’s approximately one in four of every dollar spent on healthcare in America.

The study references findings from 54 unique peer-reviewed publications, government-based reports and other sources. It focuses on six sources of inefficiency in the system and identifies “opportunities to address those inefficiencies, and underscore several key solutions to make health care more affordable for all Americans”. The six sources of inefficiency, or “waste domains”, identified and the estimated annual savings achievable through intervention according to the researchers are:

1.    Failure of Care Delivery – $44.4 – $93.3 billion in savings through intervention

2.    Failure of Care Coordination – $29.6 – $38.2 billion

3.    Overtreatment or low-value care – $12.8 – $28.6 billion

4.    Pricing Failure – $81.4 – $91.2 billion

5.    Fraud and Abuse – $22.8 – $30.8 billion

6.    Administrative Complexity – Researchers found no studies that focused on interventions targeting administrative complexity, however this category represents the greatest source of waste.

Of these six, two of the waste domains listed in the research can be directly impacted through interventions affecting patients’ financial experiences – Pricing Failure and Administrative Complexity. Together, these two categories represent potential savings of between $329.4 – $339.2 billion annually when using the $248 billion in waste attributable to administrative complexity calculated earlier this year in a report from the Center for American Progress.

The JAMA research report calls out a number of inefficiencies and suggests interventions that include more seamless data interoperability and improved pricing transparency, particularly as it affects the price of prescription medication. But price transparency has a much broader relevance when considering the industry as a whole and the patients’ increasingly prominent role as a revenue source to the healthcare industry.

Pricing Failure and Healthcare Price Transparency – The Big Picture

Many of healthcare’s inefficiencies stem from the industry’s freedom from market pressures faced by the rest of the American economy. For decades, the financial dynamic in healthcare was driven by the relationship between healthcare providers and the health insurance plan companies who covered their patients.

For most of that time, patients didn’t care much about how much their care cost. Their health plan premiums and copays were low, and the plan covered the rest. Then, starting in the early 2000s, high deductible health plans were introduced by employers who could no longer afford to absorb outsized annual increases of their employees’ coverage. These increases were due in large part to government policy and U.S. lifestyle changes, as described in in-depth analysis from online publication The Balance.

Since then, costs have continued to soar, affecting not just out-of-pocket expenses associated with higher deductibles and copays, but higher patient premiums too. Recent research from the Kaiser Family Foundation reported that average annual family premiums for healthcare topped $20,000 in 2018 for the first time. That’s $20,000 per year, per family – plus their deductibles and copays.

American healthcare consumers are struggling as a result. In a report published this summer by Kaiser Family Foundation, the cost of care “ranks at the top of things Americans worry about. It also plays a significant role in the patient experience from decisions on whether or not to get care to the impact of medical bills after receiving care.” But patients aren’t the only ones struggling. Providers, too, are feeling the adverse effects of today’s dysfunctional patient payment system as they deal with mounting patient bad debt.

This challenging financial scenario is driving a number of fundamental changes to the way patients perceive and select healthcare providers. More than ever before, patients are beginning to research their healthcare options, with a decided preference for those who present reliable cost estimates and convenient access to care. This is particularly true among younger consumers as reported in Loyale Healthcare analysis published earlier in the year.

Today’s environment has also opened the door to innovative new competitors and care delivery models. Haven Healthcare, the joint healthcare venture formed by Amazon, Berkshire Hathaway and JP Morgan Chase, Walmart Health, CVS Health and Walgreens Health are examples. All of these ventures bring a proven, customer-centric perspective to the business of delivering care, and the assurance that it will be easier to access and – most importantly – more affordable.

Finally, Patient Consumerism Has Arrived

When high deductible plans were introduced, it was believed that patients’ higher out-of-pocket expenses would motivate them to be more selective about when and where to get care. What was missing in this calculation was the fact that patients didn’t have access to the price and quality information they needed to make informed decisions. Instead, they kept doing what they had always done, with one glaring exception – according to a patient survey conducted by westhealth institute and NORC at the University of Chicago in 2018, nearly 40% of respondents reported skipping a recommended test or treatment and 44% said they didn’t go to a doctor when they were sick or injured.

More recently, however, several important new trends have been noted. A report published by TransUnion Healthcare found that 75% of patients research costs on provider and payer websites and other sources, and that the information they find impacts their decisions. 62% said that knowing out-of-pocket expenses in advance impacts the likelihood that they’ll seek care, and 49% said that clear information on healthcare out-of-pocket expenses impacts their decision to use a healthcare provider.

Patients are making it clear. After ten years of waiting for the healthcare industry to voluntarily join the market, the market is forcing healthcare to join in. Price transparency, once considered too difficult and variable to estimate, is fast becoming a business imperative for healthcare providers who intend to remain relevant in what PwC describes as The New Health Economy. Topping off this market pressure are regulators and legislators who are responding to the concerns of angry constituents who can no longer endure the high cost of care, as explored in a recent Loyale article.

As participants in the consumer economy, healthcare providers that empower patients with price transparency are experiencing some surprising, positive outcomes. By presenting reliable estimates upfront, they’re attracting more patients. Even more importantly, because the conversation about price occurs early in the care interaction, the hospital and patient are able to collaborate on strategies to ensure a favorable outcome for both parties.

Additionally, the platform that enables improved transparency and more consumer-friendly financial engagement also reduces the second “waste domain” defined in the above-mentioned JAMA research report, administrative complexity.

Patient Financial Engagement to Reduce Administrative Costs and Complexity

After nearly thirty years of developing digital tools to influence positive consumer payment behavior in their interactions with complex corporate ecosystems, Loyale Healthcare developed Loyale Patient Financial Manager™, the healthcare industry’s most widely deployed end-to-end patient financial engagement platform. With it, healthcare providers are delivering the information their patients need to make important care decisions and to partner with their provider to find the surest path to care and payment.

For providers, Loyale’s technology is completely interoperable with all major technology systems currently in use as well as several emerging technologies. Further, using sophisticated data analytics, the platform automatically segments patient populations. This segmentation drives personalized communications at the right times over the right channel (email, text, chat, phone, paper), and collection workflows to improve the probability of payment.

Lastly, because the system tracks elements of the care-and-payment experience from beginning to end, its data-gathering and analysis capabilities are unparalleled, giving providers better visibility into their patients’ experiences and payment behavior than most have ever had. With better intelligence, providers can then plan to continually improve their care and operating efficiencies.

The Convergence of Waste Reduction and Consumerization

Working with healthcare providers across the country, Loyale is proving that by embracing more retail-like operating practices, health systems and hospitals can reduce costs, improve employee morale, ease administrative burdens and deliver better patient experiences.

The transition to a more market-based approach is not an easy one, culturally or operationally, but with the right tools and partner it can be achieved more quickly than most providers imagine. And – by combining improved efficiency with better collections and a more competitive consumer profile, the dividends are compelling, even game changing. We at Loyale are privileged to work with healthcare’s game changers to help accelerate the transition.

Kevin Fleming is the CEO of Loyale Healthcare

Loyale Patient Financial Manager™ is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.

Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale recently announced an Enterprise level strategic partnership with Parallon including deployment of its industry leading technology to all HCA hospitals and Physician Groups.

New Study Probes Into People Who Believe in Ghosts


People who believe in ghosts are more open to the existence of other supernatural phenomena.

People who believe in ghosts are not afraid to entertain the possibility of other supernatural phenomena.

When we contemplate the vastness of our universe, it seems mathematically improbable that we are the only sentient beings that exist in the universe.

Halloween is the perfect excuse for adults to broaden their imaginations and entertain the improbable, the mysterious, and the unknown, and become someone or something else (well, Halloween and Comic Con). Suddenly, undead creatures and phantoms come crawling out of the darkness. Zombies, witches, and vampires come to life. For some people, however, the world of the paranormal isn’t one of imagination and fiction. In a newly released study conducted by the researchers at Queendom.com, certain people take the supernatural very seriously.

Researchers examined data collected from 13,940 people who believe ghosts. It turns out that their beliefs extend far beyond the supernatural. According to Queendom’s study, here’s what else they believe in:

DESTINY/FATE

  • 83% believe that certain people are meant to cross our paths.
  • 71% believe that if two people are meant to be together, they will be.
  • 71% believe that certain people are destined for greatness.
  • 77% believe in karma, and that what goes around comes around.
  • 65% believe in soulmates.
  • 56% believe in past lives.
  • 51% believe in reincarnation.
  • 44% believe that horoscopes are accurate.

RELIGIOUS BELIEFS

  • 79% believe in God or other divine entity.
  • 72% believe in angels.
  • 54% believe in the devil.
  • 63% believe in heaven.
  • 53% believe in hell.
  • 76% believe in miracles.
  • 80% believe in life after death.
  • 67% believe that divine beings can, and have, appeared to bring messages.
  • 55% believe faith healing.

PARANORMAL/ PSYCHIC PHENOMENA

  • 77% believe in prophecies and/or premonitions.
  • 71% believe that the dead can get in touch with the living through a medium or in dreams.
  • 66% believe that some spirits cannot rest until unfinished business is taken care of.
  • 63% believe in telepathy.
  • 58% believe in witches.
  • 58% believe that certain people are gifted with the ability to read minds.

EXTRATERRESTRIALS

  • 68% believe there is life on other planets.
  • 48% believe that aliens have already visited, while 47% that the government is hiding proof of this.

Interestingly, not many believers nor non-believers in ghosts entertain superstitious beliefs. Among the list of superstitions, fear of negative thoughts causing a tragedy, and a fear of “jinxing” something were the most common. Those who do not believe in the existence of ghosts were dismissive of most other paranormal and supernatural phenomena, with the exception of a marginal belief in God (35%), karma (32%), miracles (31%) and, most prominently, life on other planets (45%).

“Many people have an inexplicable draw to the paranormal,” explains Dr. Jerabek, president of PsychTests, the parent company of Queendom. “The idea that everything is energy, and thus can be influenced by intention or thought, is deeply compelling. Faith in reincarnation helps us come to terms with our own mortality and fear of death. Belief in cosmic interconnectedness helps us feel less lonely. When we contemplate the vastness of our universe, it seems mathematically improbable that we are the only sentient beings that exist in the universe. The fact is, as we begin to explore the world beyond our own, whether it’s with space shuttles into other galaxies or EVP recorders in a haunted building, we pave the way for new discoveries. Some people may think it foolish to entertain the prospect of aliens or ghosts, but consider this: Space flight was considered impossible. The existence of black holes was only a theory. Komodo Dragons, Goblin Sharks, and Giant Squids were thought to be fictional creatures. Things that once appeared impossible no longer seem farfetched. What we know is just the tip of the iceberg of the vast wisdom available to us … all we need to do is use science to search for the truth, keep an open mind, refuse to accept dogma of any kind … and maybe, just maybe, have a little faith.”

Want to assess your paranormal beliefs? Check out our Paranormal Beliefs Test at https://www.queendom.com/tests/access_page/index.htm?idRegTest=710

To learn more about psychological testing, download this free eBook: http://hrtests.archprofile.com/personality-tests-in-hr

About PsychTests AIM Inc.

PsychTests AIM Inc. originally appeared on the internet scene in 1996. Since its inception, it has become a pre-eminent provider of psychological assessment products and services to human resource personnel, therapists, academics, researchers and a host of other professionals around the world. PsychTests AIM Inc. staff is comprised of a dedicated team of psychologists, test developers, researchers, statisticians, writers, and artificial intelligence experts (see ARCHProfile.com). The company’s research division, Plumeus Inc., is supported in part by Research and Development Tax Credit awarded by Industry Canada.

Share article on social media or email:

Med-IQ partners with JDRF on T1D education


Med-IQ, Inc., the leading provider of clinical and risk management education, consulting services, and quality improvement solutions, announced that it has partnered with JDRF, the leading global organization funding type 1 diabetes (T1D) research, to provide a comprehensive educational initiative on T1D for clinicians, Type 1 Diabetes: The State of Affairs.

In the United States, approximately 1.25 million individuals have T1D, which includes about 200,000 youth and more than 1 million adults. Among these individuals, only 17% of youth and 21% of adults are reaching their HbA1c goals.

“We are excited to partner with Med-IQ to bring this education to clinicians,” said Sydney Yovic, Chief of Staff at JDRF. “This education supports JDRF’s mission to help improve lives today and tomorrow by accelerating life-changing breakthroughs to cure, prevent, and treat T1D and its complications.”

Type 1 Diabetes: The State of Affairs focuses on the comprehensive care of T1D and incorporates a multifaceted approach that includes the following components:

  • Webcasts—This webcast series focuses on providing the latest information in T1D management, including diabetes technologies, adjunctive therapies, and psychosocial care, to help improve patient engagement and outcomes.
  • Live workshops—Designed for primary care clinicians, this live workshop series provides an interactive forum led by expert faculty and examines real-life case examples. Upcoming workshops will be held on October 25th in San Francisco, CA, and Hartford, CT, and November 15th in Tampa, FL.
  • E-brief resources—These short resources address diabetes distress, patient assessment, and solutions for reducing and managing symptoms.

“Technological advances and new therapies continue to emerge. With the incidence of T1D expected to increase to 5 million people by 2050, it is imperative that primary care clinicians, pharmacists, and certified diabetes educators stay up-to-date on all aspects. This educational series is a great step, and we are proud to work with JDRF on this important initiative.” –Allison Gardner, Vice President of Education Strategy and Content

This activity is funded in part by JDRF and The Leona M. and Harry B. Helmsley Charitable Trust and supported by an educational grant from Novo Nordisk, Inc.

About Med-IQ

Med-IQ empowers individuals at every level of the healthcare delivery system with the knowledge they need to continuously improve provider performance and patient outcomes. Med-IQ has delivered unique educational experiences and services across the country and around the world, has been extensively published, and is proud to be one of the most award-winning accredited medical education providers in the United States.

About JDRF

JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent, and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement, and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF.

Share article on social media or email: